LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors - Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort Meeting Abstract
| Authors: | Hamilton, E. P.; Jackson, C. C.; Eskander, R. N.; Backes, F. J.; Makker, V.; Musa, F.; Olawaiye, A.; Alldredge, J.; Pothuri, B.; Secord, A. A.; Concin, N.; Martin, A. G.; Go, J.; Wride, K.; Lepley, D. M.; Cameron, T.; Patel, M. R. |
| Abstract Title: | LIO-1: Lucitanib + nivolumab in patients with advanced solid tumors - Updated phase 1b results and initial experience in phase 2 ovarian cancer cohort |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603141 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.5538 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5538 -- Source: Wos |
